Start here if you're new
what it is
Healthpeak owns healthcare buildings and collects rent from doctors, labs, and senior housing operators.
how it gets paid
Last year Healthpeak Prop made $604M in revenue. outpatient medical office was the main engine at $453M, or 75% of sales.
why it's growing
Revenue grew 6.2% last year. $448M mattered most because a landlord with only $604M in trailing annual revenue just printed a quarter worth nearly three-quarters of that figure.
what just happened
The quarter was all about scale: revenue hit $448M, up 198% vs. prior year, while EPS stayed negative at -$0.06.
At a glance
B++ balance sheet — above average — nothing keeping you up at night
30/100 earnings predictability — expect surprises
555.3x trailing p/e — you're paying up for this one
7.3% dividend yield — cash in your pocket every quarter
3.0% return on capital — nothing to write home about
xvary composite: 50/100 — below average
What they do
Healthpeak owns healthcare buildings and collects rent from doctors, labs, and senior housing operators.
Healthcare real estate is sticky because moving a clinic or lab is a headache you avoid until you must. Healthpeak owns 697 properties, and 75% of its facilities are outpatient medical buildings. REIT (real estate investment trust) → a company that owns rent-producing property → so what: you are buying rent streams, not biotech moonshots.
How they make money
$604M
annual revenue · their business grew +6.2% last year
outpatient medical office
$453M
flat
lab life science
$121M
up
continuing care retirement
$30M
flat
other
$0M
flat
The products that matter
owns and leases medical real estate
Healthcare Property Portfolio
$604M revenue · 697 properties
this portfolio generates the reported $604M of annual revenue across 697 properties. that's the business.
core
develops and re-leases properties
Development and Leasing Activity
growth data thin here
the snapshot does not break out revenue for development activity, which matters because the investment case still leans on improving growth from a $604M base.
watch
sells and recapitalizes assets
Capital Recycling
$1B+ potential proceeds
management says opportunistic sales and recapitalizations could generate more than $1B. if that happens, the cash can strengthen the balance sheet or fund new developments.
optionality
Key numbers
7.3%
dividend yield
You are being paid 7.3% a year to own a landlord with average risk rank 3, which is the whole reason most people show up here.
555.3x
trailing p/e
P/E (price-to-earnings) → how much you pay for each dollar of profit → so what: you are paying a luxury multiple for a company with almost no current earnings.
45.0%
operating margin
Operating margin → profit left after running the properties → so what: the buildings themselves still throw off cash even while bottom-line EPS looks messy.
697
properties
Scale matters in real estate. A 697-property portfolio gives DOC reach that smaller healthcare landlords cannot match.
Financial health
B++
strength
- balance sheet grade B++ — above average financial health
- risk rank 3 — safer than 50% of stocks
- price stability 80 / 100
- net profit margin 15.9% — keeps 16 cents of every dollar in revenue
- return on equity 6% — $0.06 profit for every $1 investors have put in
B++ — functional but not a standout on the balance sheet.
Total return vs. market
You invested $10,000 in DOC 3 years ago → it's now worth $7,810.
The index would have given you $13,920.
source: institutional data · total return
What just happened
missed estimates
The quarter was all about scale: revenue hit $448M, up 198% vs. prior year, while EPS stayed negative at -$0.06.
Quarterly revenue jumped to $448M from the SEC filing, and the base data called third-quarter results respectable. EPS was still -$0.06, which tells you rent collection is working better than bottom-line conversion.
$448M
revenue
$0.06
eps
198%
revenue growth
the number that mattered
$448M mattered most because a landlord with only $604M in trailing annual revenue just printed a quarter worth nearly three-quarters of that figure.
-
healthpeak properties is seeing a turning point in its business.
-
leading indicators in life sciences are turning positive with a sentiment shift in the biopharma sector, driven by heightened m&a activity, solid clinical data readouts, lower interest rates and reduced regulatory uncertainty.
-
meantime, private market values for outpatient medical buildings are strengthening, as inflation and interest rates have declined.as a result, the reit is in various stages of negotiation on opportunistic sales and recapitalizations that could generate proceeds exceeding $1 billion. these would further strengthen the balance sheet and could be recycled into highly pre-leased new outpatient medical developments or used to acquire distressed lab properties offering significant upside.
-
third-quarter results were respectable.
-
the reit delivered in line financial and operating performance.
source: company earnings report, 2026
Get this snapshot in your inbox
This page, delivered free — plus weekly updates when the numbers change. plain english, no spam.
weekly updates
earnings alerts
plain english
no spam
What could go wrong
the top threat is interest-rate pressure on healthcare property values and capital costs.
med
rates stay higher for longer
DOC is a 7.3% yielding REIT with a $12B market cap. when rates stay high, income stocks lose relative appeal and property values usually do not get more generous.
that pressure hits both valuation and financing flexibility at the same time.
med
the life sciences recovery stalls
management is pointing to better biopharma sentiment and stronger leading indicators. if that optimism fades, the promised turning point stays a talking point.
the snapshot gives no segment breakout, which means you have less visibility than you would want into where the $604M revenue base is really healing.
med
the $1B capital recycling plan does not materialize
asset sales and recapitalizations only help if buyers show up at acceptable prices. stronger private-market values are helpful. they are not a signed purchase agreement.
if proceeds fall short, DOC loses a clean way to strengthen the balance sheet or fund new developments without added strain.
a rate-driven reset would pressure all three pillars of the story at once: the 7.3% yield, the $12B equity value, and the hoped-for $1B of recycling proceeds.
source: institutional data · regulatory filings · risk analysis
Pay attention to
earnings
the next earnings print
after a -$0.17 Q4 EPS print, you want to see whether results are actually improving or just clearing a low bar.
trend
life sciences leasing sentiment
management is calling out a better biopharma backdrop. that needs to turn into occupancy and rent, not just nicer conference-panel language.
risk
interest-rate direction
DOC's income appeal and property values both care about rates. REIT math gets less forgiving when yields elsewhere rise.
metric
follow-through on the $1B+ asset plan
if opportunistic sales and recapitalizations close near the stated $1B opportunity, the balance-sheet story gets more credible fast.
Analyst rankings
short-term outlook
below average
momentum score 4 — in human-speak, analysts do not expect DOC to be a near-term leader.
risk profile
average
stability score 3 — neither defensive enough to hide in nor volatile enough to call speculative.
chart momentum
average
technical score 3 — the chart is not screaming reversal and it is not collapsing either.
earnings predictability
30 / 100
earnings predictability is weak. translation: surprises are part of the package.
source: institutional data
Institutional activity
institutions have been net buying for 3 consecutive quarters — 385 buyers vs. 313 sellers in 3q2025. total institutional holdings: 0.7B shares. net buying for 3 quarters.
source: institutional data
Price targets
3-5 year target range
$14
$25
$17
current price
$20
target midpoint · +20% from current · 3-5yr high: $25 (+50% · 15% ann'l return)
Want the deeper analysis?
The full deep dive: dcf model, scenario analysis, competitive moat breakdown, and quarterly tracking — everything on this page, taken further.
see plans from $5/moThe deep dive